当前位置: X-MOL 学术Nat. Rev. Rheumatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Bimekizumab safe and effective for AS and PsA in long-term trials
Nature Reviews Rheumatology ( IF 29.4 ) Pub Date : 2022-08-03 , DOI: 10.1038/s41584-022-00823-2
Robert Phillips 1
Affiliation  

Three new reports of results from two clinical trials of bimekizumab indicate that it is safe and efficacious for the long-term treatment of patients with ankylosing spondylitis or psoriatic arthritis.

中文翻译:

Bimekizumab 在长期试验中对 AS 和 PsA 安全有效

bimekizumab的两项临床试验的三份新结果报告表明,它对强直性脊柱炎或银屑病关节炎患者的长期治疗是安全有效的。
更新日期:2022-08-03
down
wechat
bug